Evidence map›Paper›PMID 41632809›Full record

ArticlePLoS pathogens2026

Inhibitory NK receptor expression associates with altered antimalarial function of γδ T cells.

Meagan E Olive, Perri C Callaway, Mikias Ilala, Justine Levan, Gonzalo R Acevedo, Felistas Nankya, Emmanuel Arinaitwe, John Rek, Prasanna Jagannathan, Grant Dorsey and 2 more

Abstract read
In one paragraph

Article in PLoS pathogens, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Adipocyte-derived LTB4 programs human NKG2AJournal for immunotherapy of cancer · 2026
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Meagan E OliveDepartment of Medicine, San Francisco General Hospital, University of California, San Francisco, San Francisco, California, United States of America.
Perri C CallawayDepartment of Medicine, San Francisco General Hospital, University of California, San Francisco, San Francisco, California, United States of America.
Mikias IlalaDepartment of Medicine, San Francisco General Hospital, University of California, San Francisco, San Francisco, California, United States of America.
Justine LevanDepartment of Medicine, San Francisco General Hospital, University of California, San Francisco, San Francisco, California, United States of America.
Gonzalo R AcevedoDepartment of Medicine, San Francisco General Hospital, University of California, San Francisco, San Francisco, California, United States of America.
Felistas NankyaInfectious Diseases Research Collaboration, Kampala, Uganda.
Emmanuel ArinaitweInfectious Diseases Research Collaboration, Kampala, Uganda.
John RekInfectious Diseases Research Collaboration, Kampala, Uganda.
Prasanna JagannathanDepartment of Medicine, Stanford University, Stanford, California, United States of America.
Grant DorseyDepartment of Medicine, San Francisco General Hospital, University of California, San Francisco, San Francisco, California, United States of America.
Moses R KamyaInfectious Diseases Research Collaboration, Kampala, Uganda.
Margaret E FeeneyDepartment of Medicine, San Francisco General Hospital, University of California, San Francisco, San Francisco, California, United States of America.ORCID https://orcid.org/0000-0002-2515-2989

Funding

Transmission ProjectU19AI089674 · NIAID · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI MATTHEW G DORSEY, MOSES Robert KAMYA · 2010 to 2026
$29.3M
The role of γδ T cells in fetal and infant immune defense against malariaR01AI093615 · NIAID · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI FEENEY, MARGARET E · 2011 to 2025
$9.1M
Mentoring Translational Researchers for Careers in Pediatric Global HealthK24AI113002 · NIAID · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI FEENEY, MARGARET E · 2014 to 2023
$1.9M
NIAID NIH HHS K24 AI113002NIAID NIH HHS R01 AI093615NIAID NIH HHS U19 AI089674
6 · The paper itself

Abstract

Gamma delta (γδ) T cells are important mediators of the immune response to childhood malaria. Human Vγ9+Vδ2+ T cells possess intrinsic, HLA-independent responsiveness to Plasmodium falciparum phosphoantigens produced in the blood stage of malaria. Engagement of the γδ T cell receptor (TCR) by phosphoantigen-bound butyrophilin molecules results in Vγ9+Vδ2+ T cell expansion, pro-inflammatory cytokine production, and release of cytotoxic granules that mediate parasite killing. Repeated P. falciparum infection, however, leads to a reduction in circulating Vγ9+Vδ2+ T cells and upregulation of immunomodulatory molecules, including NK receptors, that correlates with less severe symptoms upon infection. We explore phenotypic and functional differences of γδ T cells in Ugandan children with high versus low malaria exposure, utilizing high-parameter spectral flow cytometry analysis of PBMCs. We observed significant differences in expression of inhibitory NK receptors - KIR2DL1, KIR2DL2/3, KIR3DL1, LILRB1, and NKG2A - on γδ T cell subsets, with Vγ9+Vδ2+ T cells exhibiting a divergent mechanism of control compared to other subsets. We found that NKG2A and KIR3DL1 expression associated with potent Vγ9+Vδ2+ T cell responses to TCR- and Fc receptor (FcR)-mediated stimulation while KIR2DL1, KIR2DL2/3 and LILRB1 associated with reduced degranulation and cytokine production. These results identify a new role for inhibitory NK receptors expressed on γδ T cells, exerting a finely tuned balance of activating and inhibitory signals to regulate the response to malaria-related antigens.

Indexed as

Malaria, FalciparumPlasmodium falciparumReceptors, Antigen, T-Cell, gamma-deltaReceptors, Natural Killer CellT-LymphocytesChildChild, PreschoolFemaleHumansMaleReceptors, ImmunologicReceptors, Antigen, T-Cell, gamma-deltaReceptors, ImmunologicReceptors, Natural Killer Cell

Identifiers

PMID41632809
PMCPMC12880742

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.